Skip to main content
Premium Trial:

Request an Annual Quote

BioFire Submits 510(k) for High Throughput FilmArray Torch, Respiratory Panel

NEW YORK (GenomeWeb) – BioMérieux subsidiary BioFire Diagnostics announced today it has submitted its FilmArray Torch platform for special 510(k) clearance to the US Food and Drug Administration.

The firm will seek device modification for the high throughput platform for use with the FilmArray Respiratory Panel (RP).

The Torch platform is an integrated, random and continuous access system for syndromic infectious disease molecular testing, BioFire noted in a statement. It consists of scalable modules, the firm said — a two-module system would be able to test 42 patient samples per day, while a 12-module system would be capable of testing up to 262 patient samples per day.

"This submission highlights our continued effort to provide our customers with the most innovative molecular infectious disease diagnostic solutions," BioFire CEO Randy Rasmussen said in the statement.

Like the standard FilmArray platform, Torch will integrate sample preparation, amplification, and pathogen detection in a closed multiplex PCR reaction requiring two minutes of hands-on time and an hour run time. The FilmArray RP, meanwhile, is a panel of 20 respiratory viruses and bacteria performed on nasopharyngeal swab samples.

The firm also announced it will submit its other existing FDA-cleared FilmArray panels for 510(k) with the high throughput Torch system.

BioFire's Blood Culture Identification sepsis panel was initially cleared in 2013, while its gastrointestinal panel for detecting bacteria, viruses, and parasites that can cause infectious diarrhea cleared the following year, and a panel to detect pathogens causing meningitis and encephalitis cleared this past October. The respiratory panel was initially granted 510(k) clearance in 2011, when BioFire Diagnostics was still named Idaho Technology. BioMérieux acquired BioFire Diagnostics in early 2014 for a total price of $486 million.

The global installed base in clinical labs of FilmArray was about 2,000 systems at the end of September, 2015, while revenue nearly doubled, "underscoring the rapid adoption of syndromic infectious disease testing in the US," the firm said in the statement.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.